Abstract
The evolution of research into inherited haemoglobin disorders posed some fascinating questions for historians of the medical sciences in the twentieth century. Of particular interest is how the study of what initially seemed to be a group of rare genetic anaemias turned out to be the forerunner of a new era of medical science. For, in effect, it was the description of their molecular basis that led to the idea of 'molecular disease', and, later, to 'molecular medicine' — a change of emphasis from the characterization of illness in patients and their organs to a description of its pathology at the level of cells and molecules.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bannerman, R. M. Thalassemia. A Survey of Some Aspects (Grune and Stratton, New York and London, 1961).
Weatherall, D. J. in Blood, Pure and Eloquent (ed. Wintrobe, M. M.) 373–414 (McGraw-Hill, New York, 1980).
Wintrobe, M. M. Hematology, the Blossoming of a Science: A Story of Inspiration and Effort (Lea and Febiger, Philadelphia, 1985).
Weatherall, D. J. & Clegg, J. B. The Thalassaemia Syndromes 4th edn (Blackwell Science, Oxford, 2001).
Bianco, I. in The Thalassaemic Syndromes: A Symposium in Honour of Ezio Silvestroni and Ida Bianco 11–61 (Accademia Nazionale dei Lincei, Rome, 1999).
Perutz, M. F. in The Thalassaemic Syndromes: A Symposium in Honour of Ezio Silvestroni and Ida Bianco 131–136 (Accademia Nazionale dei Lincei, Rome, 1999).
Ranney, H. M. in Disorders of Hemoglobin (eds Steinberg, M. H., Forget, B. G., Higgs, D. R. & Nagel, R. L.) 1–24 (Cambridge Univ. Press, Cambridge, 2001).
Cooley, T. B. & Lee, P. A series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans. Am. Pediatr. Soc. 37, 29 (1925).
Whipple, G. H. & Bradford, W. L. Racial or familial anemia of children associated with fundamental disturbances of bone and pigment metabolism (Cooley-Von Jaksch). Am. J. Dis. Child. 44, 336–365 (1932).
Angelini, V. Primi risultati di ricerche ematologiche nei familiari di ammalati di anemia di Cooley. Min. Med. 28, 331–332 (1937).
Caminopetros, J. Recherches sur l'anémia érythroblastique infantile des peuples de la Mediterranée orientale. Etude anthropologique, étiologique et pathogénique. La transmission hereditaire de la maladia. Ann. Méd. 43, 104–125 (1938).
Silvestroni, E. & Bianco, I. Microcitemia e morbo di Cooley. Boll. Atti Acad. Med. Roma 71, 3–4 (1945).
Wintrobe, M. M., Mathews, E., Pollack, R. & Dobyns, B. M. Familial hemopoietic disorder in Italian adolescents and adults resembling Mediterranean disease (thalassemia). JAMA 114, 1530–1538 (1940).
Neel, J. V. & Valentine, W. N. Further studies on the genetics of thalassaemia. Genetics 32, 38–63 (1947).
Haldane, J. B. The rate of mutation of human genes. Proc. VIII Int. Cong. Genetics. Hereditas 35, 267–273 (1949).
Chini, V. & Valeri, C. M. Mediterranean hemopathic syndromes. Blood 4, 989–1013 (1949).
Conley, C. L. in Blood, Pure and Eloquent (ed. Wintrobe, M. M.) 319–317 (McGraw-Hill Book Company, New York, 1980).
Pauling, L., Itano, H. A., Singer, S. J. & Wells, I. G. Sickle-cell anemia, a molecular disease. Science 110, 543–548 (1949).
Vecchio, F. Sulla resistenza della emoglobina alla denaturazione alcalina in alcune sindromi emopatiche. Pediatria 54, 545–548 (1946).
Kunkel, H. G., Ceppellini, R., Müller-Eberhard, U. & Wolf, J. Observations on the minor basic hemoglobin component in blood of normal individuals and patients with thalassemia. J. Clin. Invest. 36, 1615–1625 (1957).
Ingram, V. M. Specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 178, 792–794 (1956).
Perutz, M. F. et al. Structure of haemoglobin. Nature 185, 416–422 (1960).
Rich, A. Studies on the hemoglobin of Cooley's anemia and Cooley's trait. Proc. Natl Acad. Sci. USA 38, 187–196 (1952).
Silvestroni, E. & Bianco, I. Una nova entita nosologica: la malatia microdrepanocitica. Haematologica 29, 453–488 (1946).
Sturgeon, P., Itano, H. A. & Valentine, W. N. Chronic hemolytic anemia associated with thalassemia and sickling trait. Blood 7, 350–357 (1952).
Rigas, D. A., Kohler, R. D. & Osgood, E. E. New hemoglobin possessing a higher electrophoretic mobility than normal adult hemoglobin. Science 121, 372–375 (1955).
Ager, J. A. & Lehmann, H. Observations on some 'fast' haemoglobins: K, J, N and Bart's. Br. Med. J. 34, 929–931 (1958).
Ramot, B., Sheba, C., Fisher, S., Ager, J. A. & Lehmann, H. Haemoglobin H disease with persistent 'Bart's' in an oriental Jewess and her daughter. Br. Med. J. 5161, 1228–1230 (1959).
Ingram, V. M. & Stretton, A. O. Genetic basis of the thalassemia diseases. Nature 184, 1903–1909 (1959).
Itano, H. A. & Pauling, L. Thalassaemia and the abnormal haemoglobins. Nature 191, 398–399 (1961).
Wolstenholme, G. E. & O'Connor, C. M. (eds) The Biochemistry of Human Genetics. Ciba Foundation Symposium (Little, Brown and Co., Boston, 1959).
Fessas, P. Inclusions of hemoglobin in erythroblasts and erythrocytes of thalassemia. Blood 21, 21–32 (1963).
Marks, P. A. & Burka, E. R. Hemoglobins A and F: formation in thalassemia and other hemolytic anemias. Science 144, 552–553 (1964).
Heywood, J. D., Karon, M. & Weissman, S. Amino acids: incorporation into α and β-chain of hemoglobin by normal and thalassemic reticulocytes. Science 146, 530–531 (1964).
Weatherall, D. J., Clegg, J. B. & Naughton, M. A. Globin synthesis in thalassemia: an in vitro study. Nature 208, 1061–1065 (1965).
Clegg, J. B., Naughton, M. A. & Weatherall, D. J. Abnormal human haemoglobins. Separation and characterisation of the α- and β-chains by chromatography, and the determination of two new variants, Hb Chesapeake and Hb J (Bangkok). J. Mol. Biol. 19, 91–108 (1966).
Dintzis, H. M. Assembly of the peptide chains of hemoglobin. Proc. Natl Acad. Sci. USA 47, 247–250 (1961).
Clegg, J. B., Weatherall, D. J., Na-Nakorn, S. & Wasi, P. Haemoglobin synthesis in β-thalassaemia. Nature 220, 664–668 (1968).
Clegg, J. B. & Weatherall, D. J. Haemoglobin synthesis in α-thalassaemia (haemoglobin H disease). Nature 215, 1241–1243 (1967).
Brimhall, B. et al. Multiple α chain loci for human hemoglobin. Clin. Res. 18, 184–186 (1970).
Lehmann, H. & Carrell, R. W. Differences between α and β chain mutants of human haemoglobin and between α and β thalassaemia. Possible duplication of the α-chain gene. Br. Med. J. 4, 748–750 (1968).
Wasi, P. The α thalassemia genes. J. Med. Assoc. Thailand. 53, 677–680 (1970).
Baglioni, C. The fusion of two peptide chains in hemoglobin Lepore and its interpretation as a genetic deletion. Proc. Natl Acad. Sci. USA 48, 1880–1886 (1962).
Weatherall, D. J. & Clegg, J. B. The α chain termination mutants and their relationship to thalassaemia. Phil. Trans. R. Soc. Lond. B 271, 411–455 (1975).
Benz, E. J. & Forget, B. G. Defect in messenger RNA for human hemoglobin synthesis in β thalassemia. J. Clin. Invest. 50, 2755–2760 (1971).
Nienhuis, A. W. & Anderson, W. F. Isolation and translation of hemoglobin messenger RNA from thalassemia, sickle cell anemia, and normal human reticulocytes. J. Clin. Invest. 50, 2458–2462 (1971).
Kacian, D. L. et al. Decreased globin messenger RNA in thalassemia detected by molecular hybridization. Proc. Natl Acad. Sci. USA 70, 1886–1890 (1973).
Housman, D., Forget, B. G., Skoultchi, A. & Benz, E. J. Quantitative deficiency of chain specific messenger ribonucleic acids in the thalassemia syndromes. Proc. Natl Acad. Sci. USA 70, 1809–1813 (1973).
Old, J. M. et al. Characterization of β-globin mRNA in the β thalassemias. Cell 14, 289–298 (1978).
Chang, J. C. & Kan, Y. W. β thalassemia, a nonsense mutation in man. Proc. Natl Acad. Sci. USA 76, 2886–2889 (1979).
Weatherall, D. J., Clegg, J. B. & Boon, W. H. The haemoglobin constitution of infants with the haemoglobin Bart's hydrops foetalis syndrome. Br. J. Haemat. 18, 357–367 (1970).
Ottolenghi, S. et al. The severe form of α thalassaemia is caused by a haemoglobin gene deletion. Nature 251, 389–392 (1974).
Taylor, J. M. et al. Genetic lesion in homozygous α-thalassaemia (hydrops foetalis). Nature 251, 392–393 (1974).
Embury, S. H., Lebo, R. V., Dozy, A. M. & Kan, Y. W. Organization of the α-globin genes in the Chinese α-thalassemia syndromes. J. Clin. Invest. 63, 1307–1310 (1979).
Orkin, S. H. et al. The molecular basis of α-thalassemias: frequent occurrence of dysfunctional α loci among non-Asians with Hb H disease. Cell 17, 33–43 (1979).
Orkin, S. H., Old, J. M., Weatherall, D. J. & Nathan, D. G. Partial deletion of β-globin gene DNA in certain patients with β-thalassemia. Proc. Natl Acad. Sci. USA 76, 2400–2404 (1979).
Spritz, R. A. et al. Base substitution in an intervening sequence of a β+ thalassemic human globin gene. Proc. Natl Acad. Sci. USA 78, 2455–2459 (1981).
Westaway, D. & Williamson, R. An intron nucleotide sequence variant in a cloned β+ thalassaemia globin gene. Nucleic Acids Res. 9, 1777–1788 (1981).
Antonarakis, S. E., Boehm, C. D., Giardina, P. V. & Kazazian, H. H. Non random association of polymorphic restriction sites in the β-globin gene complex. Proc. Natl Acad. Sci. USA 79, 137–141 (1982).
Higgs, D. R. et al. Analysis of the human α-globin gene cluster reveals a highly informative genetic locus. Proc. Natl Acad. Sci. USA 83, 5165–5169 (1986).
Orkin, S. H. et al. Linkage of β-thalassaemia mutations and β-globin gene polymorphisms with DNA polymorphisms in human β-globin gene cluster. Nature 296, 627–631 (1982).
Weatherall, D. J. & Clegg, J. B. Genetic variability in response to infection. Malaria and after. Genes Immun. 3, 331–337 (2002).
Wolman, I. J. Transfusion therapy in Cooley's anemia: growth and health as related to long-range hemoglobin levels, a progress report. Ann. NY Acad. Sci. 119, 736–747 (1964).
Keberle, H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann. NY Acad. Sci. 119, 758–768 (1964).
Nathan, D. G. & Gunn, R. B. Thalassemia: the consequences of unbalanced hemoglobin synthesis. Am. J. Med. 41, 815–830 (1966).
Modell, C. B. & Berdoukas, V. A. The Clinical Approach to Thalassaemia (Grune and Stratton, New York, 1984).
Propper, R. D., Shurin, S. B. & Nathan, D. G. Reassessment of the use of desferrioxamine B in iron overload. N. Eng. J. Med. 294, 1421–1423 (1976).
Pippard, M. J., Callender, S. T., Letsky, E. A. & Weatherall, D. J. Prevention of iron loading in transfusion-dependent thalassaemia. Lancet 1, 1178–1180 (1978).
Brittenham, G. M. et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N. Eng. J. Med. 331, 567–573 (1994).
Olivieri, N. F. et al. Survival of medically treated patients with homozygous β thalassemia. N. Eng. J. Med. 331, 574–578 (1994).
Weatherall, D. J. Phenotype–genotype relationships in monogenic disease: lessons from the thalassaemias. Nature Rev. Genet. 2, 245–255 (2001).
Kan, Y. W., Golbus, M. S., Klein, P. & Dozy, A. M. Successful application of prenatal diagnosis in a pregnancy at risk for homozygous β-thalassemia. N. Eng. J. Med. 292, 1096 (1975).
Fairweather, D. V. et al. Antenatal diagnosis of thalassaemia major. Br. Med. J. 1, 350–353 (1978).
Old, J. M. et al. First-trimester fetal diagnosis for haemoglobinopathies: three cases. Lancet 2, 1413–1416 (1982).
Thomas, E. D. et al. Marrow transplantation for thalassaemia. Lancet 2, 227–229 (1982).
Weatherall, D. 2003 William Allan Award address. The thalassemias: the role of molecular genetics in an evolving global health problem. Am. J. Hum. Genet. 74, 385–392 (2004).
Chernoff, A. I. et al. Studies on hemoglobin E. I. The clinical, hematologic, and genetic characteristics of the hemoglobin E syndromes. J. Lab. Clin. Med. 47, 455–462 (1956).
Weatherall, D. J. The Thalassaemia Syndromes 1st edn (Blackwell Science, Oxford, 1965).
Acknowledgements
I thank L. Rose for her assistance on this paper and the Leverhulme Trust for support.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Related links
Rights and permissions
About this article
Cite this article
Weatherall, D. Thalassaemia: the long road from bedside to genome. Nat Rev Genet 5, 625–631 (2004). https://doi.org/10.1038/nrg1406
Issue Date:
DOI: https://doi.org/10.1038/nrg1406
This article is cited by
-
Expanding global access to genetic therapies
Nature Biotechnology (2022)
-
Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment
Gene Therapy (2021)
-
Identification of α-thalassemia mutations in subjects from Eastern Sicily (Italy) with abnormal hematological indices and normal Hb A2
Annals of Hematology (2006)